A proliferation‐inducing ligand (APRIL) serum levels predict time to first treatment in patients affected by B‐cell chronic lymphocytic leukemia
暂无分享,去创建一个
G. Pizzolo | I. Nichele | F. Zampieri | A. Ambrosetti | F. Mosna | C. Tecchio | D. Veneri | A. Andreini | A. Al-Khaffaf | A. Leso